Advertisement
Skip to Content

Guardant Health Inc GH Stock Quote

| Rating as of

NASDAQ: GH

Last close prices updated as of Jun 09, 2023, 4:00 PM EST | USD | BATS BZX Real-Time Price
  • Last Close 32.86
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Investment Style Small Blend
  • Day Range 32.37  –  33.17
  • Year Range 20.67  –  62.75
  • Market Cap 3.8492 Bil
  • Volume / Avg 1.0 Mil /  2.0 Mil
  • Price / Sales 6.98
  • Price / Book 46.29
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis GH

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

Capital Allocation

INVESTOR

Guardant Health Earnings: Momentum Continues in Therapy Selection Liquid Biopsies

Julie Utterback Senior Equity Analyst

Analyst Note

| Julie Utterback |

Guardant Health delivered strong first-quarter results, and management increased its sales outlook for the full year. Our 2023 assumptions remain within the company's new guidance range, and we do not anticipate changing our $63 fair value estimate at first glance. Also, although our moat rating remains no-moat, we are still optimistic about Guardant's liquid biopsy pipeline, particularly for early detection of colorectal cancer, which is reflected in our positive moat trend rating.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics GH

Company Profile GH

Business Description

Guardant Health, based in Redwood City, California, provides cancer blood tests and analytics for clinical and research use, and the firm maintains research partnerships with large biopharmaceutical companies. The company offers Guardant 360, a blood-based (liquid biopsy) test for treatment selection in advanced stage cancer, and Guardant Omni, a broader gene panel for immuno-oncology research. The company’s pipeline includes Guardant Reveal (formerly Lunar-1), for cancer recurrence detection in survivors, and Lunar-2, a liquid biopsy for early detection of cancer in higher-risk individuals, with an initial focus on colorectal cancer. Additionally, Guardant offers research development services. The United States accounts for 90% of total revenue, and other markets the remaining 10%.

Contact
3100 Hanover Street
Palo Alto, CA, 94304
Industry Diagnostics & Research
Employees 1,793

Related Articles GH

Morningstar analysts hand-select direct competitors or comparable companies to provide context on the strength and durability of GH’s competitive advantage.

Guardant Health Inc

XNAS: GH

Exact Sciences Corp

XNAS: EXAS

Illumina Inc

XNAS: ILMN

Myriad Genetics Inc

XNAS: MYGN
Price
32.8687.81200.5323.30
Currency
USDUSDUSDUSD
Change
+$0.27 (0.83%) −$2.84 (3.13%) −$2.19 (1.08%) +$0.04 (0.17%)
Market Cap
3.85 Bil15.85 Bil31.70 Bil1.90 Bil
Industry
Diagnostics & Research Diagnostics & Research Diagnostics & Research Diagnostics & Research
Sector
Healthcare
Healthcare
Healthcare
Healthcare

* Trading data in this section is delayed by at least 15 minutes.

FAQs for Guardant Health Inc Stock

No. GH does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

GH’s market cap is 3.85 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

GH’s stock style is Small Core.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

GH’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare GH’s historical performance against its industry peers and the overall market.